Literature DB >> 1326896

Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions.

C Bergeron1, R Barrasso, S Beaudenon, P Flamant, O Croissant, G Orth.   

Abstract

All together, 30 genital human papillomavirus (HPV) types have been characterized so far. To evaluate the importance of HPV diversity in associated cervical diseases, we analyzed 188 biopsy specimens obtained from patients with a recent diagnosis of cervical HPV infection or intraepithelial neoplasia (CIN). Of these 188 specimens, 116 were classified as low-grade CIN (48 cases), high-grade CIN (53 cases), condylomata acuminata (10 cases), flat condylomas (five cases). Seventy-two specimens were considered nondiagnostic. Using probes specific for 18 genital HPV types, HPV DNA sequences were detected by Southern blot hybridization in 100 lesions and 21 nondiagnostic specimens. When further analyzed by the polymerase chain reaction, eight HPV-negative biopsy specimens, four CIN, and four nondiagnostic specimens were positive. Of the 129 positive biopsy specimens, 92 contained at least one of 18 known HPV types and 37 HPV that have not yet been identified. Nine specimens had more than one type. Thirteen HPV types were identified in CIN. The detection rate of HPV 16 increased from 21% in low-grade CIN to 57% in high-grade CIN. HPV 18 was detected in only 3% of CIN; HPV 31, 33, and 35 were found in 8%. HPV 30, 39, 45, 51, 52, 56, 58, and 61 were detected in 44% of low-grade CIN but in only 8% of high-grade CIN. Unidentified HPV were detected in about 25% of low-grade and high-grade CIN. Fifty-seven CIN positive for at least one HPV type were further analyzed by in situ hybridization. Thirty-five (65%) biopsy specimens were positive, including 21 of 24 low-grade CIN and 14 of 33 high-grade CIN. Ten of the 13 previously identified HPV types were detected. Thus, CIN represents an heterogeneous disease from a virologic viewpoint. This fact could explain their variable clinical evolution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326896     DOI: 10.1097/00000478-199207000-00002

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  22 in total

1.  Distribution of 14 high risk HPV types in cervical intraepithelial neoplasia detected by a non-radioactive general primer PCR mediated enzyme immunoassay.

Authors:  I Nindl; B Lotz; R Kühne-Heid; U Endisch; A Schneider
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

2.  Detection of HPV types and neutralizing antibodies in women with genital warts in Tianjin City, China.

Authors:  Xue-ling Wu; Chun-tao Zhang; Xiao-ke Zhu; You-chun Wang
Journal:  Virol Sin       Date:  2010-02-12       Impact factor: 4.327

3.  Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39.

Authors:  M Longuet; S Beaudenon; G Orth
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Cosette M Wheeler; Denise A Galloway; Constance Mao; Jesse Ho; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

5.  p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium.

Authors:  M D Jeffers; J Richmond; M Farquharson; A M McNicol
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

6.  Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.

Authors:  M H Schiffman; N B Kiviat; R D Burk; K V Shah; R W Daniel; R Lewis; J Kuypers; M M Manos; D R Scott; M E Sherman
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix.

Authors:  W al-Saleh; P Delvenne; J E Arrese; A F Nikkels; G E Piérard; J Boniver
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium.

Authors:  F Mota; N Rayment; S Chong; A Singer; B Chain
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

9.  Intermethod variation in detection of human papillomavirus DNA in cervical smears.

Authors:  H L Smits; L J Bollen; S P Tjong-A-Hung; J Vonk; J Van Der Velden; F J Ten Kate; J A Kaan; B W Mol; J Ter Schegget
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Cost-effectiveness of a potential vaccine for human papillomavirus.

Authors:  Gillian D Sanders; Al V Taira
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.